Drug Safety, Medical Device, And Laboratory Regulation
US Congress 111th Congress
Access to Medical Treatment Act [HB-3261]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
[Consumer Protection ]
Access to Medical Treatment Act - Gives an individual the right to be treated by a health care practitioner with any medical treatment that the individual desires, including a treatment that is not approved, certified, or licensed by the Secretary of Health and Human Services (HHS), if: (1) the practitioner has personally examined the individual and agrees to treat the individual; and (2) the administration of such treatment does not violate licensing laws. Authorizes health care practitioners to provide any method of treatment to such an individual
(continued...)
Sponsored by: Rep. Dan Burton
Referred To The Subcommittee On Health. on 07/21/2009
Spread the world
Gettr US Congress 111th Congress
National Knee and Hip Replacement Registry Act of 2009 [HB-2813]
[Healthcare ]
[Medicare and Medicaid ]
[Public Health ]
[Science ]
[Technology and Innovation ]
National Knee and Hip Replacement Registry Act of 2009 - Directs the Secretary of Health and Human Services (HHS) to establish within the Agency for Healthcare Research and Quality (AHRQ) a national knee and hip replacement registry for identifying predictors that may lead to poor outcomes in knee and hip replacement surgeries. Directs: (1) the Administrator of the Centers for Medicare and Medicaid Services, in coordination with the Director of AHRQ, to develop policies and procedures for the development and maintenance of the registry; (2) the
(continued...)
Sponsored by: Rep. Bill Pascrell
Referred To The Subcommittee On Health. on 06/11/2009
Spread the world
US Congress 111th Congress
Drug Free Water Act of 2009 [HB-276]
[Environmental ]
[Water ]
[Public Health ]
[Pharmaceuticals ]
[Waste Management / Recycling ]
Drug Free Water Act of 2009 - Requires the Administrator of the Environmental Protection Agency (EPA) to convene a task force to develop: (1) recommendations on the proper disposal of unused pharmaceuticals to prevent or reduce the detrimental effects caused by introducing such materials into water systems and for limiting the disposal of unused pharmaceuticals through treatment works in accordance with the Federal Water Pollution Control Act (commonly known as the Clean Water Act); and (2) a strategy for educating the public on such recommendations.
(continued...)
Sponsored by: Rep. Candice Miller
Referred To The House Committee On Transportation And Infrastructure. on 01/07/2009
Spread the world
US Congress 111th Congress
Counterfeit Drug Enforcement Act of 2009 [HB-2726]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
[Consumer Protection ]
[Crime ]
[Funding ]
Tim Fagan's Law or the Counterfeit Drug Enforcement Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act to establish a criminal fine and/or imprisonment for a person who: (1) knowingly causes a prescription drug to be adulterated, misbranded, or misrepresented as an approved prescription drug and sells or trades the drug; or (2) purchases or trades for such drug knowing or having reason to know that the drug was knowingly adulterated, misbranded, or misrepresented. Requires a manufacturer of a drug to notify the Secretary of Health and
(continued...)
Sponsored by: Rep. Steve Israel
Referred To The Subcommittee On Health. on 06/08/2009
Spread the world
US Congress 111th Congress
Vaccine Safety and Public Confidence Assurance Act of 2009 [HB-2618]
[Healthcare ]
[Public Health ]
[Science ]
[Pharmaceuticals ]
Vaccine Safety and Public Confidence Assurance Act of 2009 - Amends the Public Health Service Act to establish the Agency for Vaccine Safety Evaluation in the Office of the Secretary of Health and Human Services (HHS). Requires the Director for Vaccine Safety Evaluation to: (1) conduct or support safety research and monitor licensed vaccines; (2) develop a vaccine safety research agenda; (3) evaluate means to promote compliance with federal adverse reaction reporting requirements; (4) provide a clearinghouse for vaccine studies; (5) ensure that
(continued...)
Sponsored by: Rep. Carolyn Maloney
Referred To The Subcommittee On Health. on 06/02/2009
Spread the world
US Congress 111th Congress
Mercury-Free Vaccines Act of 2009 [HB-2617]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
[Science ]
[Children and Youth ]
Mercury-Free Vaccines Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act to deem a banned mercury-containing vaccine to be adulterated. Amends the Public Health Service Act to provide that a vaccine is a banned mercury-containing vaccine if one dose of the vaccine contains one or more micrograms of mercury in any form. Authorizes the Secretary of Health and Human Services (HHS) to declare that an actual or potential bioterrorist incident or other public health emergency makes the administration of such vaccines advisable for a specified
(continued...)
Sponsored by: Rep. David Price
Referred To The Subcommittee On Health. on 06/02/2009
Spread the world
US Congress 111th Congress
Skin Cancer Prevention, Education, and Consumer Right-To-Know Act [HB-2088]
[Healthcare ]
[Consumer Protection ]
[Public Health ]
[Education ]
[Pharmaceuticals ]
Skin Cancer Prevention, Education, and Consumer Right-To-Know Act - Requires the proposed rule issued by the Commissioner of Food and Drugs pertaining to over-the-counter sunscreen drug products to take effect 180 days after enactment of this Act, unless the Commissioner issues a final rule that includes formulation, labeling, and testing requirements for both ultraviolet B (UVB) and ultraviolet A (UVA) radiation protection before such time. Directs the Secretary of Health and Human Services to implement a general, nationwide education campaign
(continued...)
Sponsored by: Rep. Nita Lowey
Referred To The Subcommittee On Health. on 04/27/2009
Spread the world
US Congress 111th Congress
Prescription Drug Affordability Act [HB-163]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Senior Citizens ]
[Taxes ]
[Consumer Protection ]
Prescription Drug Affordability Act - Amends the Internal Revenue Code to allow a nonrefundable tax credit for 80 percent of the amount paid for a prescribed drug during the taxable year (and not compensated for by insurance or otherwise) by a taxpayer who has attained social security retirement age.Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to repeal provisions restricting the importation of prescription drugs. Allows a person who meets applicable legal requirements to be an importer of prescription drugs upon application to the Secretary
(continued...)
Sponsored by: Rep. Bennie Thompson
Referred To The Subcommittee On Health. on 01/14/2009
Spread the world
US Congress 111th Congress
Preservation of Antibiotics for Medical Treatment Act of 2009 [HB-1549]
[Healthcare ]
[Public Health ]
[Animals ]
[Food ]
[Pharmaceuticals ]
Preservation of Antibiotics for Medical Treatment Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to deny an application for a new animal drug that is a critical antimicrobial animal drug unless the applicant demonstrates that there is a reasonably certainty of no harm to human health due to the development of antimicrobial resistance attributable to the nontherapeutic use of the drug. Defines "critical antimicrobial animal drug" as a drug intended for use in food-producing animals
(continued...)
Sponsored by: Rep. Raul Grijalva
Committee Hearings Held. on 07/13/2009
Spread the world
US Congress 111th Congress
Counterfeit Drug Prevention Act of 2009 [HB-1450]
[Pharmaceuticals ]
[Healthcare ]
[Public Health ]
[Consumer Protection ]
[Crime ]
[Criminal Justice ]
[Public Safety ]
Counterfeit Drug Prevention Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act to establish criminal penalties of a fine and imprisonment for not more than 20 years, or both, for any person who commits a prohibited act relating to counterfeiting knowing that: (1) the conduct concerns the rendering of a drug as a counterfeit drug; (2) the conduct will cause a drug to be a counterfeit drug; or (3) a drug, held, sold, or dispensed is a counterfeit drug. Increases the term of imprisonment to any term of years or for life if the use of a counterfeit
(continued...)
Sponsored by: Rep. Gene Green
Referred To The Subcommittee On Crime, Terrorism, And Homeland Security. on 04/27/2009
Spread the world
US Congress 111th Congress
Promoting Innovation and Access to Life-Saving Medicine Act [HB-1427]
[Healthcare ]
[Pharmaceuticals ]
[Science ]
[Technology and Innovation ]
[Consumer Protection ]
[Public Health ]
Promoting Innovation and Access to Life-Saving Medicine Act - Amends the Public Health Service Act to provide for the licensing of biosimilar and interchangeable biological products. Defines "biosimilar" and "interchangeability" for purposes of this Act. Allows any person to file an abbreviated biological product application with the Secretary of Health and Human Services. Requires such applications to include information demonstrating a high degree of similarity or interchangeability between the biological product and the licensed biological product
(continued...)
Sponsored by: Rep. Raul Grijalva
Referred To The Subcommittee On Health. on 03/12/2009
Spread the world
US Congress 111th Congress
Healthy Americans Act [HB-1321]
[Healthcare ]
[Insurance ]
[Medicare and Medicaid ]
[Public Health ]
[Children and Youth ]
[Taxes ]
[Funding ]
[Budget and Spending ]
Healthy Americans Act - Requires each adult individual to have the opportunity to purchase a Healthy Americans Private Insurance Plan (HAPI), which is: (1) a plan offered by a state; or (2) an employer-sponsored health coverage plan. Makes individuals who are not enrolled in another specified health plan and who are not opposed to coverage for religious reasons responsible for enrolling themselves and their dependent children in a HAPI plan offered through their state of residence. Sets forth penalties for failure to enroll. Establishes standardized
(continued...)
Sponsored by: Rep. Debbie Wasserman Schultz
Referred To The Subcommittee On Health. on 03/06/2009
Spread the world
US Congress 111th Congress
Family Smoking Prevention and Tobacco Control Act [HB-1256]
[Healthcare ]
[Public Health ]
[Consumer Protection ]
[Pharmaceuticals ]
[Family-Related Legislation ]
[Medicare and Medicaid ]
[Labor, Jobs, Employment ]
[Pensions ]
[Retirement ]
[Military ]
[Veterans ]
Division A: Family Smoking Prevention and Tobacco Control Act - Family Smoking Prevention and Tobacco Control Act - Title I: Authority of the Food and Drug Administration - (Sec. 101) Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to provide for the regulation of tobacco products by the Secretary of Health and Human Services through the Food and Drug Administration (FDA). Defines a tobacco product as any product made or derived from tobacco that is intended for human consumption. Prohibits a tobacco product from being marketed in combination
(continued...)
Sponsored by: Rep. Raul Grijalva
Became Public Law No: 111-31. on 06/22/2009
Spread the world
US Congress 111th Congress
Safe Drug Disposal Act of 2009 [HB-1191]
[Public Health ]
[Pharmaceuticals ]
[Environmental ]
[Waste Management / Recycling ]
[Law Enforcement ]
[Overdose Prevention ]
[Healthcare ]
[Public Safety ]
[Crime ]
Safe Drug Disposal Act of 2009 - Amends the Controlled Substances Act to direct the Attorney General to promulgate regulations to: (1) authorize an ultimate user or care taker (a person responsible for taking care of one or more individuals or animals) to dispose of a controlled substance in accordance with a prescribed state program; (2) include five model state programs providing for such disposal through delivery to a designated facility; and (3) allow a state to work with the Attorney General to devise an alternative disposal program that is
(continued...)
Sponsored by: Rep. Gerald Connolly
Referred To The Subcommittee On Crime, Terrorism, And Homeland Security. on 03/16/2009
Spread the world
US Congress 111th Congress
Heart Disease Education, Analysis Research, and Treatment for Women Act [HB-1032]
[Healthcare ]
[Science ]
[Public Health ]
[Funding ]
[Grants ]
Heart Disease Education, Analysis Research, and Treatment for Women Act or the HEART for Women Act - (Sec. 2) Directs to the Comptroller General to study and report to specified congressional committees on the extent to which sponsors of clinical studies of investigational drugs, biologics, and devices and sponsors of applications for approval or licensure of new drugs, biologics, and devices comply with Food and Drug Administration (FDA) requirements and follow guidance for presentation of clinical study safety and effectiveness data by sex, age,
(continued...)
Sponsored by: Rep. Steve Scalise
Received In The Senate And Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 11/15/2010
Spread the world
US Congress 116th Congress
Fair Care Act of 2020 [S.4796]
[Healthcare ]
[Insurance ]
[Pharmaceuticals ]
[Consumer Protection ]
[Public Health ]
A bill to address the high costs of health care services, prescription drugs, and health insurance coverage in the United States, and for other purposes.
Sponsored by: Sen. Mike Braun
Read Twice And Referred To The Committee On Finance. on 10/05/2020
Spread the world
US Congress 116th Congress
Fair Care Act of 2020 [HB-8527]
[Healthcare ]
[Insurance ]
[Pharmaceuticals ]
[Consumer Protection ]
[Public Health ]
To address the high costs of health care services, prescription drugs, and health insurance coverage in the United States, and for other purposes.
Sponsored by: Rep. Lloyd Smucker
Introduced In House on 10/02/2020
Spread the world
US Congress 116th Congress
Delivering Immediate Relief to America's Families, Schools and Small Businesses Act [S.4775]
[Small Business ]
[Labor, Jobs, Employment ]
[Unemployment ]
[Funding ]
[Healthcare ]
[Public Health ]
[Economic Development ]
[Budget and Spending ]
[Children and Youth ]
Establishes measures and funding to provide economic relief and support for individuals, families, and businesses in response to COVID-19 (i.e., coronavirus disease 2019). These measures include (1) implementing certain liability protections, (2) extending pandemic unemployment compensation, and (3) authorizing second draw loans under the Paycheck Protection Program.
Sponsored by: Sen. Mitch McConnell
Read The Second Time. Placed On Senate Legislative Calendar Under General Orders. Calendar No. 564. on 10/01/2020
Spread the world
US Congress 116th Congress
Maternal Health Pandemic Response Act of 2020 [S.4769]
[Healthcare ]
[Public Health ]
[Labor, Jobs, Employment ]
[Family-Related Legislation ]
[Data Privacy ]
[Science ]
[Pharmaceuticals ]
[Human Services ]
[Native American Affairs ]
[Children and Youth ]
[Medicare and Medicaid ]
Addresses maternal health during the COVID-19 (i.e., coronavirus disease 2019) emergency by supporting data collection, development of COVID-19 therapeutics and workplace protections, and other activities. Specifically, the Department of Health and Human Services must issue guidance for states and local health departments on collecting data on pregnancy and postpartum status in conjunction with COVID-19 tests. In addition, the bill provides funds for the Centers for Disease Control and Prevention (CDC) to expand particular maternal health surveillance
(continued...)
Sponsored by: Sen. Cory Booker
Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 09/30/2020
Spread the world
US Congress 116th Congress
The Heroes Act [HB-8406]
[Budget and Spending ]
[Funding ]
[Grants ]
[Disaster Relief ]
Making emergency supplemental appropriations for the fiscal year ending September 30, 2021, and for other purposes.
Sponsored by: Rep. Raul Grijalva
Introduced In House on 09/29/2020